Surgery for hypertrophic cardiomyopathy

James J. Wu, Michael Seco, Caroline Medi, Chris Semsarian, David R. Richmond, Joseph A. Dearani, Hartzell V Schaff, Michael J. Byrom, Paul G. Bannon

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hypertrophic cardiomyopathy (HCM) is a genetically determined cardiac disease characterised by otherwise unexplained myocardial hypertrophy of the left ventricle, and may result in left ventricular outflow tract obstruction. It is the most common cause of sudden cardiac death in young adults due to arrhythmias. Septal myectomy is a surgical treatment for HCM with moderate to severe outflow tract obstruction, and is indicated for patients with severe symptoms refractory to medical therapy. The surgical approach involves obtaining access to the interventricular septum via transaortic, transapical or transmitral approaches, and excising a portion of the hypertrophied myocardium to relieve the outflow tract obstruction. Large, contemporary series from centres experienced in septal myectomy patients have demonstrated a low early mortality of <2 %, excellent long-term survival that matches the general population, and durable relief of symptoms.

Original languageEnglish (US)
Pages (from-to)117-125
Number of pages9
JournalBiophysical Reviews
Volume7
Issue number1
DOIs
StatePublished - 2015

Fingerprint

Hypertrophic Cardiomyopathy
Ventricular Outflow Obstruction
Sudden Cardiac Death
Hypertrophy
Heart Ventricles
Cardiac Arrhythmias
Young Adult
Heart Diseases
Myocardium
Survival
Mortality
Therapeutics
Population

Keywords

  • Alcohol septal ablation
  • Hypertrophic cardiomyopathy
  • Left ventricular outflow tract obstruction
  • Septal myectomy

ASJC Scopus subject areas

  • Biophysics
  • Molecular Biology
  • Structural Biology

Cite this

Wu, J. J., Seco, M., Medi, C., Semsarian, C., Richmond, D. R., Dearani, J. A., ... Bannon, P. G. (2015). Surgery for hypertrophic cardiomyopathy. Biophysical Reviews, 7(1), 117-125. https://doi.org/10.1007/s12551-014-0153-3

Surgery for hypertrophic cardiomyopathy. / Wu, James J.; Seco, Michael; Medi, Caroline; Semsarian, Chris; Richmond, David R.; Dearani, Joseph A.; Schaff, Hartzell V; Byrom, Michael J.; Bannon, Paul G.

In: Biophysical Reviews, Vol. 7, No. 1, 2015, p. 117-125.

Research output: Contribution to journalArticle

Wu, JJ, Seco, M, Medi, C, Semsarian, C, Richmond, DR, Dearani, JA, Schaff, HV, Byrom, MJ & Bannon, PG 2015, 'Surgery for hypertrophic cardiomyopathy', Biophysical Reviews, vol. 7, no. 1, pp. 117-125. https://doi.org/10.1007/s12551-014-0153-3
Wu JJ, Seco M, Medi C, Semsarian C, Richmond DR, Dearani JA et al. Surgery for hypertrophic cardiomyopathy. Biophysical Reviews. 2015;7(1):117-125. https://doi.org/10.1007/s12551-014-0153-3
Wu, James J. ; Seco, Michael ; Medi, Caroline ; Semsarian, Chris ; Richmond, David R. ; Dearani, Joseph A. ; Schaff, Hartzell V ; Byrom, Michael J. ; Bannon, Paul G. / Surgery for hypertrophic cardiomyopathy. In: Biophysical Reviews. 2015 ; Vol. 7, No. 1. pp. 117-125.
@article{f4271f01df3345499b4213fb090879e3,
title = "Surgery for hypertrophic cardiomyopathy",
abstract = "Hypertrophic cardiomyopathy (HCM) is a genetically determined cardiac disease characterised by otherwise unexplained myocardial hypertrophy of the left ventricle, and may result in left ventricular outflow tract obstruction. It is the most common cause of sudden cardiac death in young adults due to arrhythmias. Septal myectomy is a surgical treatment for HCM with moderate to severe outflow tract obstruction, and is indicated for patients with severe symptoms refractory to medical therapy. The surgical approach involves obtaining access to the interventricular septum via transaortic, transapical or transmitral approaches, and excising a portion of the hypertrophied myocardium to relieve the outflow tract obstruction. Large, contemporary series from centres experienced in septal myectomy patients have demonstrated a low early mortality of <2 {\%}, excellent long-term survival that matches the general population, and durable relief of symptoms.",
keywords = "Alcohol septal ablation, Hypertrophic cardiomyopathy, Left ventricular outflow tract obstruction, Septal myectomy",
author = "Wu, {James J.} and Michael Seco and Caroline Medi and Chris Semsarian and Richmond, {David R.} and Dearani, {Joseph A.} and Schaff, {Hartzell V} and Byrom, {Michael J.} and Bannon, {Paul G.}",
year = "2015",
doi = "10.1007/s12551-014-0153-3",
language = "English (US)",
volume = "7",
pages = "117--125",
journal = "Biophysical Reviews",
issn = "1867-2450",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Surgery for hypertrophic cardiomyopathy

AU - Wu, James J.

AU - Seco, Michael

AU - Medi, Caroline

AU - Semsarian, Chris

AU - Richmond, David R.

AU - Dearani, Joseph A.

AU - Schaff, Hartzell V

AU - Byrom, Michael J.

AU - Bannon, Paul G.

PY - 2015

Y1 - 2015

N2 - Hypertrophic cardiomyopathy (HCM) is a genetically determined cardiac disease characterised by otherwise unexplained myocardial hypertrophy of the left ventricle, and may result in left ventricular outflow tract obstruction. It is the most common cause of sudden cardiac death in young adults due to arrhythmias. Septal myectomy is a surgical treatment for HCM with moderate to severe outflow tract obstruction, and is indicated for patients with severe symptoms refractory to medical therapy. The surgical approach involves obtaining access to the interventricular septum via transaortic, transapical or transmitral approaches, and excising a portion of the hypertrophied myocardium to relieve the outflow tract obstruction. Large, contemporary series from centres experienced in septal myectomy patients have demonstrated a low early mortality of <2 %, excellent long-term survival that matches the general population, and durable relief of symptoms.

AB - Hypertrophic cardiomyopathy (HCM) is a genetically determined cardiac disease characterised by otherwise unexplained myocardial hypertrophy of the left ventricle, and may result in left ventricular outflow tract obstruction. It is the most common cause of sudden cardiac death in young adults due to arrhythmias. Septal myectomy is a surgical treatment for HCM with moderate to severe outflow tract obstruction, and is indicated for patients with severe symptoms refractory to medical therapy. The surgical approach involves obtaining access to the interventricular septum via transaortic, transapical or transmitral approaches, and excising a portion of the hypertrophied myocardium to relieve the outflow tract obstruction. Large, contemporary series from centres experienced in septal myectomy patients have demonstrated a low early mortality of <2 %, excellent long-term survival that matches the general population, and durable relief of symptoms.

KW - Alcohol septal ablation

KW - Hypertrophic cardiomyopathy

KW - Left ventricular outflow tract obstruction

KW - Septal myectomy

UR - http://www.scopus.com/inward/record.url?scp=84922435958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922435958&partnerID=8YFLogxK

U2 - 10.1007/s12551-014-0153-3

DO - 10.1007/s12551-014-0153-3

M3 - Article

AN - SCOPUS:84922435958

VL - 7

SP - 117

EP - 125

JO - Biophysical Reviews

JF - Biophysical Reviews

SN - 1867-2450

IS - 1

ER -